Ryan Spencer Dynavax Technologies Corp (DVAX) insider trading activity

DVAX Quotes by TradingView

Ryan Spencer is CEO and Director of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 379,620 shares of DVAX, which is worth approximately $4.2 Million. The most recent transaction as insider was on Feb 22, 2021, when has been sold 10,791 shares (Common Stock) at a price of $9.6 per share, resulting in proceeds of $103,594. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 380K
45.6% 3M change
88.84% 12M change
Total Value Held $4.2 Million

Ryan Spencer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2021
SELL
Payment of exercise price or tax liability
$103,594 $9.6 p/Share
10,791 Reduced 13.42%
69,620 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
-
20,833 Added 20.58%
80,411 Common Stock
Feb 22 2021
BUY
Grant, award, or other acquisition
$5,149 $3.39 p/Share
1,519 Added 2.49%
59,578 Common Stock
Aug 14 2020
BUY
Grant, award, or other acquisition
$5,146 $3.39 p/Share
1,518 Added 2.55%
58,059 Common Stock

Also insider at

CDTX
Cidara Therapeutics, Inc. Healthcare
Director
RS

Ryan Spencer

CEO and Director
Emeryville, CA

Track Institutional and Insider Activities on DVAX

Follow DYNAVAX TECHNOLOGIES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVAX shares.

Notify only if

Insider Trading

Get notified when an Dynavax Technologies Corp insider buys or sells DVAX shares.

Notify only if

News

Receive news related to DYNAVAX TECHNOLOGIES CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DVAX